InvestorsHub Logo
Followers 7
Posts 781
Boards Moderated 0
Alias Born 10/26/2021

Re: JPetroInc post# 10580

Tuesday, 07/19/2022 10:52:05 PM

Tuesday, July 19, 2022 10:52:05 PM

Post# of 20445
You know very well that Todos can't make the claim to treat Covid with Tollovid until they get regulatory approval, which is in process. All they can do in the meantime regarding treatment of Covid is to release case studies and continue collection of the data necessary for FDA approval. They have done an excellent job of complying with FTC requirements and have approval to label Tollovid as a 3CL Protease Inhibitor. Most people who learn even a basic knowledge of the virus can understand the connection, even if the company isn't currently allowed to spell out that connection for them. That is coming.

I am confident in the culmination of decades-long research and product formulation of a well-respected Israeli biochemist whose prior work is the basis of Pfizer's Paxlovid drug. Todos and Tollovid/Tollovir will be in the spotlight soon enough.